本页面由Tiger Trade Technology Pte. Ltd.提供服务

Amneal Pharmaceuticals, Inc.

20.03
+0.12000.60%
盘后:20.150.1200+0.60%19:50 EDT
成交量:458.82万
成交额:9,188.43万
市值:63.90亿
市盈率:41.66
高:20.28
开:20.04
低:19.86
收:19.91
52周最高:21.18
52周最低:9.56
股本:3.19亿
流通股本:1.91亿
量比:1.31
换手率:2.40%
股息:- -
股息率:- -
每股收益(TTM):0.4808
每股收益(LYR):0.2200
净资产收益率:613.02%
总资产收益率:8.60%
市净率:193.48
市盈率(LYR):91.05

数据加载中...

2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/31

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/01

重要事件披露

Form 8-K - Current report
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/05/03

重要事件披露

Form 8-K - Current report
2024/04/24

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]